Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter

Reuters Health • The Doctor's Channel Daily Newscast

Random blood glucose identifies women with overt diabetes in pregnancy

NEW YORK (Reuters Health) – Random blood glucose (RBG) measurements early in pregnancy can identify women with overt diabetes in pregnancy (ODIP), researchers from UK report in the August 15th online Diabetes Care. “Currently, the focus has been on...

Reuters Health • The Doctor's Channel Daily Newscast

Support for partial nephrectomy in clinical T1 renal cell carcinoma

NEW YORK (Reuters Health) – New research supports current clinical guidance to perform partial nephrectomy (PN) when possible in patients with clinically organ-confined renal cell tumors 7 centimeters or smaller (cT1). In a retrospective comparative...

Reuters Health • The Doctor's Channel Daily Newscast

Short course of prednisone effective for clopidogrel hypersensitivity

NEW YORK (Reuters Health) – Most patients with allergic reactions to clopidogrel do not need to stop the drug or switch to another antiplatelet drug but rather can be successfully managed with a short course of concurrent oral prednisone therapy,...

Reuters Health • The Doctor's Channel Daily Newscast

Pre-PCI ultrasound exam of access site decreases vascular complications

NEW YORK (Reuters Health) – A simple ultrasound examination of the femoral artery puncture site before elective percutaneous coronary intervention decreases the rate of subsequent vascular complications, a German team reports in the American Journal of...

Reuters Health • The Doctor's Channel Daily Newscast

Mesalamine once-daily OK for ulcerative colitis maintenance therapy

NEW YORK (Reuters Health) – For preventing relapse of ulcerative colitis (UC), mesalamine can be taken once a day rather than twice or three times daily, according to the results of a meta-analysis reported in the American Journal of Gastroenterology...

Reuters Health • The Doctor's Channel Daily Newscast

Stereotactic radiosurgery has advantages in treating brain metastases

NEW YORK (Reuters Health) – For patients with a limited number of brain metastases, treatment with stereotactic radiosurgery alone is as good as whole-brain radiotherapy plus stereotactic radiosurgery in terms of overall survival – with less risk of...

Reuters Health • The Doctor's Channel Daily Newscast

Treatment of stroke with tirofiban seen safe, may have benefits

NEW YORK (Reuters Health) – Treating patients with ischemic stroke up to 22 hours after onset with the glycoprotein IIb/IIIa platelet receptor antagonist tirofiban does not increase cerebral bleeding complications, and may decrease mortality, according...

Reuters Health • The Doctor's Channel Daily Newscast

Combination therapy of little benefit in pulmonary hypertension

NEW YORK (Reuters Health) – Treating patients with pulmonary arterial hypertension with more than one class of pulmonary vasodilator does not decrease mortality or slow progression of the disease, according the results of meta-analysis published in the...

Reuters Health • The Doctor's Channel Daily Newscast

Inhaled NO not effective for preemies at risk for respiratory failure

NEW YORK (Reuters Health) – Preterm infants requiring respiratory support do not benefit from inhaled nitric oxide (iNO), according to the results of a meta-analysis of individual patient data from multiple clinical trials. “Routine use of iNO for...

Reuters Health • The Doctor's Channel Daily Newscast

Prolonged post-PCI bivalirudin infusion has benefits in STEMI

NEW YORK (Reuters Health) – Continuing bivalirudin for 4 hours after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) facilitates early microvascular reperfusion without an increase in bleeding...